Welcome to our dedicated page for Enhabit news (Ticker: EHAB), a resource for investors and traders seeking the latest updates and insights on Enhabit stock.
Enhabit, Inc. reports developments tied to its national home health and hospice care business in the United States. The company’s Home Health segment provides Medicare-certified nursing, therapy, medical social work and aide services for adult patients, while its Hospice segment focuses on care for patients with life-limiting illnesses.
Recurring Enhabit news includes quarterly operating results, home health admissions and census trends, hospice performance, debt reduction and credit-related actions, investor presentations, material agreements, shareholder voting matters and governance updates. Company updates also cover legal and regulatory disclosures when they affect its public-company reporting or corporate matters.
Enhabit, Inc. (NYSE: EHAB) reported Q1 2024 results, highlighting net service revenue of $262.4 million, net income of $0.2 million, and Adjusted EBITDA of $25.3 million. The company saw strong growth in home health and hospice care, with positive operational metrics. Despite some declines in revenue and EPS, Enhabit remains confident in its strategy for future growth.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.